Treatment with a novel phospholipid-based drug formulation prevents behavioural deficits induced by proteasome inibition: implications for Parkinson's disease.

Typeset version

 

TY  - CONF
  - Crotty,S., Fitzgerald, P., Mandel,A.,Bolton, A.E., Sullivan, A.M., Nolan, Y.
  - Society for Neuroscience meeting, Atlanta, USA.
  - Treatment with a novel phospholipid-based drug formulation prevents behavioural deficits induced by proteasome inibition: implications for Parkinson's disease.
  - Atlanta, USA.
  - Invited Lectures (Conference)
  - 2006
  - ()
  - 1
DA  - 2006/NaN
ER  - 
@unpublished{V19908161,
   = {Crotty, S. and  Fitzgerald,  P. and  Mandel, A. and Bolton,  A.E. and  Sullivan,  A.M. and  Nolan,  Y. },
   = {Society for Neuroscience meeting, Atlanta, USA.},
   = {{Treatment with a novel phospholipid-based drug formulation prevents behavioural deficits induced by proteasome inibition: implications for Parkinson's disease.}},
   = {Atlanta, USA.},
   = {Invited Lectures (Conference)},
   = {2006},
   = {()},
   = {1},
  source = {IRIS}
}
AUTHORSCrotty,S., Fitzgerald, P., Mandel,A.,Bolton, A.E., Sullivan, A.M., Nolan, Y.
TITLESociety for Neuroscience meeting, Atlanta, USA.
PUBLICATION_NAMETreatment with a novel phospholipid-based drug formulation prevents behavioural deficits induced by proteasome inibition: implications for Parkinson's disease.
LOCATIONAtlanta, USA.
CONFERENCE_TYPEInvited Lectures (Conference)
YEAR2006
TIMES_CITED()
PEER_REVIEW1
START_DATE
END_DATE
ABSTRACT
FUNDED_BY